Literature DB >> 8785368

Cytology of pseudomyxoma peritonei.

P Pfitzer1, G Richartz.   

Abstract

The cytology of five cases of pseudomyxoma peritonei is described. It is characterized by large masses of mucinous material, some of which is wrapped up in a network of elongated fibroblast-like cells. Irregular clusters of flat branching vimentin-positive fibroblast-like cells may be found as the disease progresses. Goblet or tumour cells were not found in the cytology preparations, although they were seen in the histological sections of the one case which was biopsied. The appendiceal origin of pseudomyxoma peritonei could not be traced in three of four male patients, and the cause of the disease remained undetermined. Autopsy of the fourth case demonstrated a complete replacement of the appendix by mucus.

Entities:  

Mesh:

Year:  1995        PMID: 8785368     DOI: 10.1111/j.1365-2303.1995.tb00576.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  3 in total

1.  Application of advanced multimodality care to pseudomyxoma peritonei patient: report of first patient treated at a tertiary center.

Authors:  Arshad Bashir Khan; Youssuf Al Suhaibani; Khaled Al Mohaimed; David L Morris
Journal:  Indian J Surg Oncol       Date:  2010-12-23

Review 2.  Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review.

Authors:  Sree Harsha Tirumani; Margaret Fraser-Hill; Rebecca Auer; Wael Shabana; Cynthia Walsh; Frank Lee; John G Ryan
Journal:  Cancer Imaging       Date:  2013-02-22       Impact factor: 3.909

3.  Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles.

Authors:  Claudio Isella; Marco Vaira; Manuela Robella; Sara Erika Bellomo; Gabriele Picco; Alice Borsano; Andrea Mignone; Consalvo Petti; Roberta Porporato; Alexandra Ambra Ulla; Alberto Pisacane; Anna Sapino; Michele De Simone; Enzo Medico
Journal:  Cancers (Basel)       Date:  2020-06-08       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.